These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 39200792)

  • 1. Watchman vs. Amulet for Left Atrial Appendage Closure: Current Evidence and Future Perspectives.
    Frazzetto M; Sanfilippo C; Costa G; Contrafatto C; Giacalone C; Scandura S; Castania G; De Santis J; Sanfilippo M; Di Salvo ME; Tamburino C; Barbanti M; Grasso C
    J Clin Med; 2024 Aug; 13(16):. PubMed ID: 39200792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left Atrial Appendage Closure with Watchman vs Amulet Devices: Similarities and Differences.
    Ahmed A; Bawa D; Kabra R; Pothineni NVK; Darden D; Gopinathannair R; Lakkireddy D
    Curr Cardiol Rep; 2023 Sep; 25(9):909-915. PubMed ID: 37584874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of percutaneous Watchman 2.5 device versus Amplatzer Amulet for left atrial appendage closure in patients with non-valvular atrial fibrillation: A systematic review and study-level meta-analysis.
    Yasmin F; Ali E; Moeed A; Zaidi F; Umar M; Virwani V
    PLoS One; 2024; 19(2):e0295804. PubMed ID: 38354181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy and safety comparison of Watchman device versus ACP/Amulet device for percutaneous left atrial appendage closure in patients with nonvalvular atrial fibrillation: A study-level meta-analysis of clinical trials.
    Bing S; Chen RR
    Clin Cardiol; 2023 Feb; 46(2):117-125. PubMed ID: 36448417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of Amulet Left Atrial Appendage Occluder and Watchman Device for Left Atrial Appendage Closure in Patients With Atrial Fibrillation.
    Sawaya F; Abi-Saleh B; Hoteit A; Jdaidany J; Moumneh MB; Harbieh B; Khoury M; Aramouni S; Abdulhai F; Refaat M
    Cureus; 2024 Mar; 16(3):e55531. PubMed ID: 38576630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between Amulet and Watchman left atrial appendage closure devices: A real-world, single center experience.
    Saad M; Risha O; Sano M; Fink T; Heeger CH; Vogler J; Sciacca V; Eitel C; Stiermaier T; Joost A; Keelani A; Fuernau G; Meyer-Saraei R; Kuck KH; Eitel I; Richard Tilz R
    Int J Cardiol Heart Vasc; 2021 Dec; 37():100893. PubMed ID: 34712772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short term outcome after left atrial appendage occlusion with the AMPLATZER Amulet and WATCHMAN device: results from the ORIGINAL registry (saxOnian RegIstry analyzinG and followINg left atrial Appendage cLosure).
    Kretzler L; Mues C; Wunderlich C; Langbein A; Spitzer SG; Gerk U; Schellong S; Ketteler T; Neuser H; Schwefer M; Strasser R; Ibrahim K; Schoen S; Christoph M
    BMC Cardiovasc Disord; 2022 Jun; 22(1):271. PubMed ID: 35710343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The WATCHMAN left atrial appendage closure device for patients with atrial fibrillation: current status and future perspectives.
    Wintgens LIS; Maarse M; Swaans MJ; Rensing BJWM; Van Dijk VF; Boersma LVA
    Expert Rev Med Devices; 2020 Jul; 17(7):615-626. PubMed ID: 32543911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latest outcomes of transcatheter left atrial appendage closure devices and direct oral anticoagulant therapy in patients with atrial fibrillation over the past 5 years: a systematic review and meta-analysis.
    Takeda K; Tsuboko Y; Iwasaki K
    Cardiovasc Interv Ther; 2022 Oct; 37(4):725-738. PubMed ID: 35098478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous left atrial appendage closure with the Watchman device: a systematic review.
    Maksym J; Grabowski M; Mazurek T
    Postepy Kardiol Interwencyjnej; 2024 Mar; 20(1):18-29. PubMed ID: 38616940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and Rationale of the Swiss-Apero Randomized Clinical Trial: Comparison of Amplatzer Amulet vs Watchman Device in Patients Undergoing Left Atrial Appendage Closure.
    Galea R; De Marco F; Aminian A; Meneveau N; Anselme F; Gräni C; Huber AT; Teiger E; Iriart X; Angelillis M; Brugger N; Spirito A; Corpataux N; Franzone A; Vranckx P; Fischer U; Pedrazzini G; Bedogni F; Windecker S; Räber L; Valgimigli M
    J Cardiovasc Transl Res; 2021 Oct; 14(5):930-940. PubMed ID: 33884564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left atrial appendage occlusion using LAmbre Amulet and Watchman in atrial fibrillation.
    Chen S; Chun KRJ; Bordignon S; Weise FK; Nagase T; Perrotta L; Bologna F; Schmidt B
    J Cardiol; 2019 Apr; 73(4):299-306. PubMed ID: 30583991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
    J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between Amplatzer and Watchman Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Qiao J; Zhang B; Wang J; Pan L; Cheng T; Wang Y; Xiong E
    Cardiology; 2022; 147(3):290-297. PubMed ID: 35468598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial.
    Lakkireddy D; Thaler D; Ellis CR; Swarup V; Sondergaard L; Carroll J; Gold MR; Hermiller J; Diener HC; Schmidt B; MacDonald L; Mansour M; Maini B; O'Brien L; Windecker S
    Circulation; 2021 Nov; 144(19):1543-1552. PubMed ID: 34459659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amulet device implantation following incomplete left atrial appendage closure with Watchman legacy device.
    Yoon SH; Elgendy AY; Dallan LAP; Filby SJ
    Catheter Cardiovasc Interv; 2024 Jan; 103(1):226-229. PubMed ID: 37870093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of the Amplatzer Amulet and Watchman 2.5 for left atrial appendage occlusion: A systematic review and meta-analysis.
    Zhu MZ; Song H; Song GM; Bai X
    Pacing Clin Electrophysiol; 2022 Oct; 45(10):1237-1247. PubMed ID: 35933600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left Atrial Appendage Closure for Patients with Cerebral Amyloid Angiopathy and Atrial Fibrillation: the LAA-CAA Cohort.
    Schrag M; Mac Grory B; Nackenoff A; Eaton J; Mistry E; Kirshner H; Yaghi S; Ellis CR
    Transl Stroke Res; 2021 Apr; 12(2):259-265. PubMed ID: 32770310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left atrial appendage closure - Current status and future directions.
    Alfadhel M; Nestelberger T; Samuel R; McAlister C; Saw J
    Prog Cardiovasc Dis; 2021; 69():101-109. PubMed ID: 34843811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.